Association Between Plasma Level of Mannose Binding Lectin and Human Reproduction
Recruiting
Observational Study
Mannose-Binding Lectin Deficiency
Recurrent Pregnancy Loss
Recurrent Implantation Failure
Infertility
Habitual Abortion
Recurrent Miscarriage
Recurrent Spontaneous Abortion
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 41
- Sex
- Female
- Study type
- Observational
- Participants needed
- 500 (estimated)
- Sponsor
- Aalborg University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
A low plasma level of mannose binding lectin (p-MBL) is associated with unexplained recurrent pregnancy loss (RPL), but it is not investigated if it is associated with unexplained reproductive failure in general, including recurrent implantation failure (RIF) after assisted reproductive technology (ART) (including IVF, ICSI and FET), recurrent pregnancy loss (RPL) after spontaneous conception, and…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
fulfil one of the following:
* 3 consecutive pregnancy losses after spontaneous conception
* 3 consecutive pregnancy losses after assisted reproductive technology treatment (ART) including IVF, ICSI and FET
* 3 failed embryo transfers characterized by no achieved pregnancy (aft…
Contacts